Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ZXBT-1158 by Guangzhou BeBetter Medicine Technology for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
ZXBT-1158 is under clinical development by Guangzhou BeBetter Medicine Technology and currently in Phase I for Diffuse Large B-Cell Lymphoma....
ZXBT-1158 by Guangzhou BeBetter Medicine Technology for Mantle Cell Lymphoma: Likelihood of Approval
ZXBT-1158 is under clinical development by Guangzhou BeBetter Medicine Technology and currently in Phase I for Mantle Cell Lymphoma. According...
ZXBT-1158 by Guangzhou BeBetter Medicine Technology for Follicular Lymphoma: Likelihood of Approval
ZXBT-1158 is under clinical development by Guangzhou BeBetter Medicine Technology and currently in Phase I for Follicular Lymphoma. According to...
ZXBT-1158 by Guangzhou BeBetter Medicine Technology for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Likelihood of Approval
ZXBT-1158 is under clinical development by Guangzhou BeBetter Medicine Technology and currently in Phase I for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)....
ZXBT-1158 by Guangzhou BeBetter Medicine Technology for Marginal Zone B-cell Lymphoma: Likelihood of Approval
ZXBT-1158 is under clinical development by Guangzhou BeBetter Medicine Technology and currently in Phase I for Marginal Zone B-cell Lymphoma....